Table 3.
Comparison of clinical characteristics of patients with MP, RSV and multi-virus infection.
| Demographic and general characteristics | MP (n = 89) | RSV (n = 255) | Multi-virus (n = 36) |
|---|---|---|---|
| Males, n (%) | 48 (53.9) | 139 (54.5) | 21 (58.3) |
| Age, days, median (range) | 22 (1–28) | 17 (12–22) | 18 (9–20) |
| Pregnancy and delivery characteristics | |||
| Gestational age, weeks, median (range) | 37 (33–41) | 37 (31–41) | 37 (34–41) |
| Preterm delivery (<37 wk), n (%) | 4 (4.5) | 17 (6.7) | 3 (8.3) |
| Cesarean section, n (%) | 31 (34.8) | 79 (31.0) | 12 (33.3) |
| Breast feeding | 71 (79.7) | 201 (78.8) | 28 (77.8) |
| Respiratory symptoms and signs [n, (%)] | |||
| Fever (temperature, ≥38 °C) | 43 (48.3)a | 58 (22.7) | 10 (27.8) |
| Cough | 81 (91.0) | 241 (94.5) | 36 (100) |
| Tachypnea | 47 (52.8)b | 158 (62.0) | 21 (58.0) |
| Wheeze | 9 (10.1.) | 23 (9.0) | 3 (8.3) |
| Laboratory results | |||
| WBC, ×109 L–1, median (range) | 11.2 ± 3.2 | 10.5 ± 3.6 | 10.9 ± 3.4 |
| CRP > 10 mg/dL, n (%) | 8 (9.0) | 21 (8.0) | 4 (11.1) |
| ALT > 40 U/L, n (%) | 7 (7.9) | 25 (9.8) | 2 (5.6) |
| Oxygen supplementation, n (%) | 3 (2.7)a | 39 (15.3) | 4 (11.1) |
| Mechanical ventilation, n (%) | 0 | 10 (3.9) | 1 (2.8) |
| Hospital stay, days, median (range) | 7 (4–12)a | 10 (9–14) | 9 (7–14) |
MP, Mycoplasma pneumoniae; RSV, respiratory syncytial virus; WBC, white blood cell counts; CRP, C-reactive protein; ALT, alanine transaminase.
a
p < 0.01 compared with RSV and multi-virus infection.
b
p < 0.01 compared with RSV infection.